Idea
Munich, Bayern, Germany
About Idea
IDEA AG develops and commercializes non-invasive targeted therapeutics applied through the skin for delivery of drugs. The company uses Transfer some carriers for transporting the established molecular weight drugs selectively into the skin. It focuses on dermatological and pain therapeutics. The company’s Diractin is a ketoprofen in the Transfersome gel for the treatment of peripheral pain. IDEA AG was founded in 1993 and is based in Munich, Germany.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Apr 2015)
- Website: idea-ag.de
- Phone: +49893246330
Industries & Categories
Biotechnology, Developer Platform, Therapeutics
Canonical: https://fsome.com/organization/idea-2543135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.